Did you ever hear of bonus pills when buying Aciphex at your local pharmacy?

Eisai Co., Ltd. (TSE: 4523) has announced the dedication of a new formulation facility, N1 Building, at the Misato Plant in Saitama Prefecture.
The N1 Building will enable the company to expand the production capacity for the proton pump inhibitor, ACIPHEX / PARIET (rabeprazole sodium), thereby meeting increasing worldwide demand while reducing the production cost.
In addition, the facility has incorporated pack…

Prevacid Held Slight Lead in Proton Pump Inhibitor Sales to Retailers
for 2004

Sales in billions of dollars

Prevacid $3.80
Nexium $3.78
Protonix $2.33
Aciphex $1.33
Omeprazole $0.64

Note: Based on purchases, at wholesale prices, by retailers of
prescription drugs. Total U.S. sales for proton pump inhibitor class
were $12.5 billion.
Source: IMS Health
KEVIN FOLEY, RESEARCH/JULIE KELLER, DESIGN

Note: Table made from bar graph.

C…

The Food and Drug Administration has approved expanded use for Aciphex (rabeprazole sodium), a protonpump inhibitor, as a treatment for daytime and nighttime heartburn and other symptoms associated with gastr…

The first seven-day treatment of H. pylori infection has been approved by the Food and Drug Administration. Aciphex, a proton pump inhibitor, is being copromoted by Eisai Go. (its Japanese-based developer) and Janssen Pharmaceutica Inc. (a unit of Johnson & Johnson). H. pylori, a type of stomach bacteria, is the most common cause of peptic ulcers.

Related Results
…

Aciphex (rabeprazole sodium, Eisai Corporation)
The Food and Drug Administration approved an adolescent indication for Aciphex (rabeprazole sodium) 20 mg for short-term treatment of gastroesophageal reflux disease in patients 12 years and older.
* Recommended Dosage: A 20-mg oral dose daily for up to 8 weeks is recommended for adolescents aged 12 years and over. The tablets can be …

TEANECK, N.J.–Eisai Inc. and Janssen Pharmaceutica Inc. have unveiled a revised look for Aciphex (rabeprazole sodium) bottles and tablets. The revamped design for the product, a treatment for erosive gastroesophageal reflux disease, features larger bottles, color-coded labels and imprinted tablets.
The new 20-mg. Tablets are…

After nearly a quarter of a century in leadership communications roles at Bristol-Myers Squibb and Novartis, Robert Laverty signed on in April as VP, US corporate communications at Eisai Corporation of North America. He’s excited about the opportunity to help the company increase co…

Denver, CO - LegalView, the number one resource for everything and anything legal on the Internet, recently alerted patients taking proton pump inhibitor (PPI) drugs of the potential for serious bone fracture risks associated with taking the medication. A study published in a recent issue of the Canadian Medical Association Journal found that patients using PPIs for continued use (5 to 7 years or more) are at an increased risk of developing hip, spinal or wrist fractures. According to the study,…

March 18, 2008 (Philadelphia) — If you’re one of the millions of women who
suffer from heartburn during pregnancy, a cautionary note: New research
suggests that some acid-blocking drugs used to treat the condition can ra…

If you’ve ever had a persistent cough and weren’t sure about the cause, it likely never crossed your mind that it might be associated to acid reflux. This is due to the fact that there seems to be a lack of a relationship between the two. A cough is far more frequently a symptom of the common cold or long time smoking or case of bronchitis or pneumonia. It’s rarely thought of as a symptom of acid reflux.
Gast…